Together we plan to develop multiple new SOLiD system-specific protocols focused on paired-end-Tags (PET).  What does this mean for you and me?  Such protocols will allow us to better understand the genetic basis of diseases such as cancers, which in turn, help improve diagnosis and treatments of such deadly diseases.

The SOLiD System provides more accuracy than other next-gen technologies out there, which is especially important for variation studies. As part of this collaboration, GIS will add two SOLiD systems to its current fleet, bringing GIS’ total number of SOLiD systems to six.

“We expect that the protocols developed in this collaboration will contribute to the advancement of research in cancer and other human diseases. GIS’ use of SOLiD clearly demonstrates the importance of this technology to the future of genome sequencing.” – Ben Hwang, head of the Asia Pacific region for Life Technologies.

“Combining GIS’ paired-end-Tag technology with LIFE Technologies’ SOLiD technology will bring about significant advancements in the area of translational research.  This will be very important for early detection, prevention, and treatment of diseases.” – Dr. Ruan Yijun, associate director for GIS’ genome technology development.